Calcitriolo Mylan generics 0.25 mcg

Calcitriolo Mylan generics is a pharmaceutical product containing Calcitriol, a synthetic form of Vitamin D3. It is used to treat bone diseases associated with chronic kidney failure and conditions like hypoparathyroidism. The brand Mylan has a long history, founded in 1961 in West Virginia, USA, as a small distributor before becoming a global giant in the generic drug industry.

In November 2020, Mylan merged with Upjohn, a division of Pfizer, to form a new global healthcare company called Viatris. This merger combined Mylan's extensive generic portfolio with Upjohn's iconic brands. While Viatris is headquartered in the United States, its manufacturing operations are globally distributed. Many of its generic products, including active ingredients for formulations like Calcitriol, are produced in large-scale facilities in India (under Mylan Laboratories Limited) and various European sites. In Italy, the product is distributed and managed by Viatris Italia S.r.l.